COIL and prostate carcinoma: In response to platinum drug treatments, prostate cancer cells exhibited highly heterologous changes in distribution of Coilin-immunopositivity in relation to nucleoli (Fig. 5) with frequent localization of Coilin close or within the nucleoli.